These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29956165)

  • 41. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A lentivirus-free inducible CRISPR-Cas9 system for efficient targeting of human genes.
    Bisht K; Grill S; Graniel J; Nandakumar J
    Anal Biochem; 2017 Aug; 530():40-49. PubMed ID: 28477963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Creating Genome Modifications in C. elegans Using the CRISPR/Cas9 System.
    Calarco JA; Friedland AE
    Methods Mol Biol; 2015; 1327():59-74. PubMed ID: 26423968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.
    Ryø LB; Thomsen EA; Mikkelsen JG
    Methods Mol Biol; 2019; 1961():93-109. PubMed ID: 30912042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells.
    Mandl M; Ritthammer H; Ejaz A; Wagner SA; Hatzmann FM; Baumgarten S; Viertler HP; Zwierzina ME; Mattesich M; Schiller V; Rauchenwald T; Ploner C; Waldegger P; Pierer G; Zwerschke W
    Adipocyte; 2020 Dec; 9(1):626-635. PubMed ID: 33070670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Assessing abundance and specificity of different types of sgRNA targeting miRNA precursors].
    Liu HL; Shen Y; Gao Y; Zhou L; Han XS; Zhao CZ; Yang GJ; Chen YL; Yang H; Xie SS
    Yi Chuan; 2018 Jul; 40(7):561-571. PubMed ID: 30021719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome Editing Using CRISPR/Cas9 System in the Rice Blast Fungus.
    Arazoe T
    Methods Mol Biol; 2021; 2356():149-160. PubMed ID: 34236684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of CRISPR/Cas9 for the Modification of the Mouse Genome.
    Klimke A; Güttler S; Kuballa P; Janzen S; Ortmann S; Flora A
    Methods Mol Biol; 2019; 1953():213-230. PubMed ID: 30912024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells.
    Bellec J; Bacchetta M; Losa D; Anegon I; Chanson M; Nguyen TH
    Curr Gene Ther; 2015; 15(5):447-59. PubMed ID: 26264708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CRISPR/Cas9-mediated genome editing in sea urchins.
    Lin CY; Oulhen N; Wessel G; Su YH
    Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid and Efficient Gene Deletion by CRISPR/Cas9.
    Neldeborg S; Lin L; Stougaard M; Luo Y
    Methods Mol Biol; 2019; 1961():233-247. PubMed ID: 30912049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
    Kumar R; Tiwari K; Saudagar P
    Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Novel System for Simple Rapid Adenoviral Vector Construction to Facilitate CRISPR/Cas9-Mediated Genome Editing.
    Bi Y; Gu L; Wang J; Chang Y; Jin M; Mao Y; Wang H; Ji G
    CRISPR J; 2021 Jun; 4(3):381-391. PubMed ID: 34077671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
    Zou RS; Liu Y; Ha T
    STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knockdown of Human AMPK Using the CRISPR/Cas9 Genome-Editing System.
    Grenier A; Sujobert P; Olivier S; Guermouche H; Mondésir J; Kosmider O; Viollet B; Tamburini J
    Methods Mol Biol; 2018; 1732():171-194. PubMed ID: 29480475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells.
    Voets O; Tielen F; Elstak E; Benschop J; Grimbergen M; Stallen J; Janssen R; van Marle A; Essrich C
    PLoS One; 2017; 12(8):e0182974. PubMed ID: 28800587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR/Cas9 as a tool to dissect cancer mutations.
    Sayed S; Paszkowski-Rogacz M; Schmitt LT; Buchholz F
    Methods; 2019 Jul; 164-165():36-48. PubMed ID: 31078796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRISPR/Cas: A powerful tool for gene function study and crop improvement.
    Zhang D; Zhang Z; Unver T; Zhang B
    J Adv Res; 2021 Mar; 29():207-221. PubMed ID: 33842017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.